Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease

NCT01810185 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Low patient enrollment

Conditions

Inflammatory Bowel Disease
Crohn's Disease
Ulcerative Colitis

Interventions

DRUG: Low dose naltrexone
DRUG: Placebo

Sponsor

Santa Barbara Cottage Hospital